Detalhe da pesquisa
1.
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial.
Clin Infect Dis
; 69(9): 1498-1505, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30601976